Aivita Biomedical's new skincare line, Root of Skin, has sold out during its debut on QCV Japan.
Aivita Biomedical is a biotech company based in Irvine, CA. Leveraging its expertise in stem cell biology, the company has developed a skin care technology which aims to recreate the microenvironment responsible for the growth and maintenance of human skin. Comprised of components which support early skin development, the technology represents a novel and promising approach in the pursuit of younger, healthier looking skin.
The Root of Skin collection includes Revitalizing Face Renewal Serum and Revitalizing Eye Renewal Complex, which recently sold out in 45 minutes of its debut on QVC Japan --marking the first time a stem cell-based skincare product was offered on the network.
"QVC Japan is one of the biggest sales channels in one of the largest skincare markets in the world," said Christi Douglass, Aivita's Marketing and Business Development Officer. "A sell-out launch is reassuring as we prepare to launch our professional line Root of Skin MD to physicians throughout Japan."
Dr. Hans S. Keirstead, Aivita's Chairman and CEO adds, "Not only has a revolutionary skincare product disrupted the marketplace...An Aivita mission has been realized: 100% of the proceeds from Root of Skin sales are being used to treat women with ovarian cancer."